Metformin
Hyperinsulinism
Attikon HospitalSmall moleculePhase 4 / ApprovedActive
BB
67/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 57/ 100
- Competitive Position
- 81/ 100
Competitive context
17 Active assets in the Hyperinsulinism cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Eudemine Injection Columbia University | Phase 2 | B |
Insulin-Like Growth Factor I Children's Hospital of Philadelphia | Phase 2 | B |
Rosiglitazone New York Medical College | Phase 2 | B |
Vigabatrin University of Arizona | Phase 2 | CCC |
Pasireotide Montefiore Medical Center | Phase 2 | CCC |
View all 23 →
Same molecule, other indications
Metformin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →